OUR PARTNERS
CONTACT US
About
Management Team
Board of Directors
Veterinary Advisory Board
Products
MYOS Canine Muscle Formula®
Physician Muscle Health Formula®
Yolked®
Scientific Research
SPORTS NUTRITION - University of Tampa Clinical Study
HEALTHY AGING – University of California at Berkeley Clinical Study
PET NUTRITION – Kansas State University Canine Clinical Study
Investor Relations
Overview
Analyst Coverage
News / Events
Company Information
Financial Information
SEC Filings
Corporate Governance
Menu
Press Releases
Overview
Analyst Coverage
News / Events
Press Releases
IR Calendar
Email Alerts
Company Information
Profile
Management Team
IR Contacts
Financial Information
Financials
Quarterly Results
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Board of Directors
Governance Docs
Email Alerts
Fact Sheet
IR Contacts
RSS News Feed
All News
By Year:
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Feb 24, 2021
MYOS CORP Secures Fourth Patent as Part of R&D Drive to Address Healthcare Burden of Sarcopenia and Muscle-Related Disorders
Feb 2, 2021
MYOS CORP Announces Formation of Veterinary Advisory Board
Jan 19, 2021
YOLKED® Sports Nutrition to Be Presenting Sponsor of Championship 7v7 Football Series in 2021
Dec 21, 2020
MYOS CORP Enters Exclusive Agreement with Science Biotech to Distribute Fortetropin® Products in Australia and New Zealand
Dec 15, 2020
MYOS CORP, Formerly Known as Myos Rens Technology, Inc., Issues Notice to its Shareholders
Dec 9, 2020
MYOS CORP Announces Positive Results from Mobility and Quality of Life Study in Geriatric and Arthritic Dogs at Kansas State University
Dec 7, 2020
MYOS CORP Enters into Agreement with a Leading Hong Kong Supplement Distributor, Smart Supplement Ltd., to Distribute YOLKED® Sports Nutrition Products in Hong Kong and Southeast Asian Countries
Nov 24, 2020
MYOS Corp Receives a New Patent from the United States Patent and Trademark Office Significantly Enhancing its Musculoskeletal Health Intellectual Property Portfolio
Nov 17, 2020
MYOS RENS TECHNOLOGY BOARD OF DIRECTORS approved the Reverse Stock Split ratio of one new share for every 12 shares of Common Stock outstanding
Nov 12, 2020
MYOS RENS Technology Announces anticipated exchange ratio, immediately after the completion of the Merger
1
2
3
4
5
6
7
8
9
10
...19
Next >>
Show All